Showing results (111-120 of 149) with videos related to
Sort By:
Pageof 15
Chempluschem|January 22, 2020
Zwitterionic Modification of Ultrasmall Iron Oxide Nanoparticles for Reduced Protein Corona FormationKarina Pombo-García, Carmen L Rühl, Raymond Lam, et al.Journal of Medicinal Chemistry|July 29, 2014
Ligand-induced conformational change of Plasmodium falciparum AMA1 detected using 19F NMRXiaopeng Ge, Christopher A MacRaild, Shane M Devine, et al.Journal of Medicinal Chemistry|December 14, 2016
Novel Irreversible Agonists Acting at the A<sub>1</sub> Adenosine ReceptorManuela Jörg, Alisa Glukhova, Alaa Abdul-Ridha, et al.Advanced Drug Delivery Reviews|June 1, 2019
Unlocking the full potential of lipid-based formulations using lipophilic salt/ionic liquid formsHywel D Williams, Leigh Ford, Annabel Igonin, et al.Chemmedchem|June 23, 2021
1,3-Benzodioxole-Modified Noscapine Analogues: Synthesis, Antiproliferative Activity, and Tubulin-Bound StructureCassandra Yong, Shane M Devine, Anne-Catherine Abel, et al.Journal of the American Chemical Society|January 15, 2009
Total synthesis of the potent anticancer Aglaia metabolites (-)-silvestrol and (-)-episilvestrol and the active analogue (-)-4'-desmethoxyepisilvestrolTim E Adams, Mariana El Sous, Bill C Hawkins, et al.Journal of Medicinal Chemistry|February 16, 2018
A Structure-Activity Relationship Study of Bitopic N<sup>6</sup>-Substituted Adenosine Derivatives as Biased Adenosine A<sub>1</sub> Receptor AgonistsLuigi Aurelio, Jo-Anne Baltos, Leigh Ford, et al.European Journal of Medicinal Chemistry|May 31, 2021
Discovery and development of 2-aminobenzimidazoles as potent antimalarialsShane M Devine, Matthew P Challis, Jomo K Kigotho, et al.Journal of Pharmaceutical Sciences|May 28, 2017
Transformation of Biopharmaceutical Classification System Class I and III Drugs Into Ionic Liquids and Lipophilic Salts for Enhanced Developability Using Lipid FormulationsHywel D Williams, Leigh Ford, Shea Lim, et al.Molecular Pharmacology|April 26, 2018
Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M<sub>1</sub> Muscarinic Acetylcholine ReceptorsEmma T van der Westhuizen, Arthur Spathis, Elham Khajehali, et al.Pageof 15